Shamar J Young
- Professor, Radiology & Imaging Sci - (Clinical Scholar Track)
- Chief, Interventional Radiology Division
Biography
Dr. Young received a Bachelor of Science degree in Microbiology graduating cum laude from the University of Florida. He went on to complete his Doctor of Medicine degree and Diagnostic Radiology Residency at the University of Florida in 2010 and 2015, respectively. Following residency, Dr. Young completed an Interventional Radiology Fellowship at the University of Minnesota in 2016 and accepted a faculty position in the Department of Radiology. In 2022, Dr. Young accepted the position of IR Chief, joining the University of Arizona and Banner University Medicine.
Dr. Young is passionate about clinical translation and research. His clinical expertise is in the areas of interventional oncology, portal hypertension, and advanced emboltherapy. He currently serves as principal investigator and co-co-principal investigator in thirty clinical studies involving procedures and therapies aimed at improving patient care and outcomes.
Dr. Young has published seventy papers, the majority of which he is first author. He serves as reviewer for fifteen international journals, and commonly presents abstracts at national and international meetings.
An active committee member for many professional societies, Dr. Young currently serves as Co-chair for the Research Committee Global Embolization Symposium and Technologies (GEST) and Chair of the Society of Interventional Radiology: Early Career Section.
CVIR Endovascular awarded Dr. Young Outstanding Service to the Journal Award for “Prostate embolization: patient, selection clinical management and results”. He is consistently named on the “Top Doctors Rising Stars” list, appearing four consecutive years and was named amongst the Minnesota Monthly’s Top Doctors list in 2021.
Degrees
- M.D.
- Cum laude, University of Florid, Gainesville, Florida, United States
- B.S.
- Cum laude, University of Florid, Gainesville, Florida, United States
Work Experience
- University of Arizona, Tucson, Arizona (2022 - Ongoing)
- University of Minnesota Medical School (2021 - 2022)
- University of Minnesota Medical School (2017 - 2021)
- University of Minnesota Medical School, Radiology (lnterventional Radiology) (2016 - 2017)
Awards
- Top Doctors Rising Stars, Mpls-St.Paul Magazine
- Mpls-St.Paul Magazine, Spring 2022
- Top Doctors Rising Stars
- Mpls-St.Paul Magazine, Summer 2021
- Mpls-St.Paul Magazine, Summer 2020
- Mpls-St.Paul Magazine, Summer 2019
- Minnesota Monthly’s Top Doctors
- Minnesota Monthly’s Top Doctors, Spring 2021
- Outstanding Service to the Journal Award for “Prostate embolization: patient, selection clinical management and results”. CVIR Endovascular
- Outstanding Service to the Journal Award for “Prostate embolization: patient, selection clinical management and results”. CVIR Endovascular, Summer 2020
- Lawrence M Goodman Medical Scholarship, University of Florida
- University of Florida, Fall 2007
- Member, National Society of Collegiate Scholars
- National Society of Collegiate Scholars, Fall 2007
- Charlotte Liberty Medical Scholarship, University of Florida
- University of Florida, Fall 2006
- Member, Phi Kappa Phi Honor Society
- Phi Kappa Phi Honor Society, Fall 2006
Licensure & Certification
- Arizona Medical License (2020)
- ACLS (2011)
- BLS (2022)
- DEA (2016)
- Minnesota Medical License, University of Minnesota Medical School (2016)
Interests
Research
My research interest lie in the are of local regional therapy. Specifically I have been active in evaluating dose thresholds for cancer treated with transarterial radioembolization, evaluating how transarterial radioembolization affects the immune system and prediction models for thermal ablation.
Courses
No activities entered.
Scholarly Contributions
Journals/Publications
- More infoBackgroundPelvic pain caused by malignant and non-malignant etiologies can be treated by cryoneurolysis of the pudendal nerve(s). The purpose of this report is to assess the efficacy and safety of CT-guided pudendal nerve cryoneurolysis. Additionally, treatment outcomes were compared between malignant and non-malignant pelvic pain etiologies.MethodsPatients who underwent CT-guided pudendal nerve cryoneurolysis for intractable pelvic pain were retrospectively reviewed. Pre-procedural and post-procedural pain scores, supplemental analgesic use, and complications were assessed.ResultsA total of 30 patients underwent CT-guided pudendal nerve cryoneurolysis. Pre-treatment Visual Analog Scale (VAS) pain scores were significantly improved at 1 week (3.9 ± 2.1, < 0.001), 1 month (4.6 ± 2.3, < 0.001), 3 months (3.9 ± 2.2, < 0.001) and 6 months (6.2 ± 3.4, < 0.001) post-treatment. Pre-treatment morphine equivalents (ME) significantly decreased at 1 week (30 (range:0-216), = 0.04) and 1 month (17.5 (range:0-216), = 0.032) post-treatment. Both malignant and non-malignant cohorts demonstrated significant improvement of VAS score at all time points; however, there was no significant difference in numeric improvement or percentage improvement in VAS score between the 2 cohorts. No adverse events were observed.ConclusionCT-guided pudendal nerve cryoneurolysis is an effective and safe treatment modality in patients with refractory pelvic pain from both malignant and non-malignant etiologies.
Reviews
- More infoQuality improvement (QI) initiatives have benefited patients as well as the broader practice of medicine. Large-scale QI has been facilitated by multi-institutional data registries, many of which were formed out of national or international medical society initiatives. With broad participation, QI registries have provided benefits that include but are not limited to establishing treatment guidelines, facilitating research related to uncommon procedures and conditions, and demonstrating the fiscal and clinical value of procedures for both medical providers and health systems. Because of the benefits offered by these databases, Society of Interventional Radiology (SIR) and SIR Foundation have committed to the development of an interventional radiology (IR) clinical data registry known as VIRTEX. A large IR database with participation from a multitude of practice environments has the potential to have a significant positive impact on the specialty through data-driven advances in patient safety and outcomes, clinical research, and reimbursement. This article reviews the current landscape of societal QI programs, presents a vision for a large-scale IR clinical data registry supported by SIR, and discusses the anticipated results that such a framework can produce.
